Sarepta Therapeutics was approached for comment by Clinical Trials Arena but did not respond before publication. This comes ...

Shares of Sarepta Therapeutics plunged more than 30% on Friday as the future of its key gene therapy treatment appeared at ...

(Bloomberg) -- The head of the US Food and Drug Administration said the agency will “take a hard look” at a gene therapy from ...

US stock futures rose slightly on Friday (July 18) after the S&P 500 closed at a record high in the previous session, with ...